Cardinal Health (CAH) Stock Could Be 9.6% Undervalued Despite Rich P/E Signals

June 21, 2026 - 00:11

Cardinal Health (CAH) has drawn investor attention after its stock closed at $221.77. This has put recent performance and current valuation metrics in focus for those tracking large U.S. healthcare distributors. While the share price slipped around 2% in the latest session, the 30-day return of 10.55% and the one-year total shareholder return of 37.25% sit alongside a very large five-year total shareholder return of 334.47%.

Despite these strong gains, some analysts suggest the stock could still be 9.6% undervalued. That claim stands out because Cardinal Health currently trades at a price-to-earnings ratio that looks rich compared to the broader market. The company operates in a sector known for steady demand, and its long-term growth has been fueled by acquisitions and expanding distribution networks.

Investors weighing the stock face a tension between the high P/E and the potential for further upside. The recent pullback in share price may offer a buying opportunity for those who believe the earnings outlook justifies the premium. However, the stock's valuation remains a key point of debate, especially as the healthcare distribution industry faces margin pressures and regulatory shifts. For now, the combination of past returns and a possible discount keeps Cardinal Health on many watch lists.